APG273

N/A

Report date: 2025/12/12 15:29:39

Base Information

Drug NameAPG273

Drug Alias NameAPG273APG-273

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionInterleukin-13 inhibitorsThymic stromal lymphopoietin inhibitors

TargetsInterleukin-13Thymic stromal lymphopoietin

Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesApogee Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesApogee Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsPulmonary Disease, Chronic ObstructiveAsthma

Inactive IndicationsN/A

Other Information

ATC CodeN/A